Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D, Mehdizadeh S, Uchiyama A, Inoue Y, Sawaya A, Overmiller A, Brooks SR, Hasneen K, Kellett M, Palazzo E, Motegi SI, Yuspa SH, Cataisson C, Morasso MI.
Bajpai D, et al. Among authors: uchiyama a.
Oncogene. 2021 May;40(21):3680-3694. doi: 10.1038/s41388-021-01802-9. Epub 2021 May 4.
Oncogene. 2021.
PMID: 33947961
Free PMC article.